大象传媒

CNPase is an enzyme present at high levels in myelinating cells. Novel nanobody tools developed in an international collaboration were used to identify binding epitopes at atomic resolution and visualise myelin. Additionally, the nanobodies were used as intrabodies to bind to CNPase in living cells. These nanotools will be valuable for future research on myelin and its molecules.

The Department of Clinical Dentistry is proud of its participation in the 饾棥饾椉饾椏饾槃饾棽饾棿饾椂饾棶饾椈 饾棗饾棶饾槅 饾棞饾棫饾棓饾棧饾棓 鈥� 饾棛饾椏饾椉饾椇 饾棩饾棽饾榾饾棽饾棶饾椏饾棸饾椀 饾榿饾椉 饾棖饾椀饾棶饾椈饾棿饾棽 at the Autumn ITAPA Conference 2024

This meeting at Solstrand August 28鈥�31, 2024 was the 2nd Research Meeting in the INTPART collaboration between CCBIO and the Vascular Biology Program (VBP), Boston Children鈥檚 Hospital and Harvard Medical School, the first being the Iceland meeting in 2019. In 2019, 48 participants met in Iceland, and this year, 57 gathered at Solstrand.

Oxygen is vital for human life and so is our ability to respond to low oxygen levels. Researchers at the University of Oxford and University of Bergen have uncovered new factors defining how human cells respond to hypoxia.

The Norwegian Cancer Society has recently allocated their 2024 grants to current cancer research projects. Eight researchers from Bergen made the final cut, including three from CCBIO.

Kari Str酶no Wagner-Larsen defended November 15, 2024 her doctoral work at the University of Bergen with the thesis "Advanced MRI for developing more personalized treatment strategies in uterine cervical cancer". Wagner-Larsen's doctoral work includes four studies showing that traditional as well as advanced, computer-assisted MRI analyses (radiomics) improve the risk assessment of patients with... Read more

A large study from Zambia, published in eClinicalMedicine, found that financial support combined with comprehensive sexuality education and community dialogue meetings, can moderately reduce adolescent births and increase the proportion of girls who complete basic education

On 14 October 2024, the EU Council formally adopted the revised Ambient Air Quality Directive (AAQD). This pivotal legislation introduces stricter limits on major air pollutants such as particulate matter (PM2.5, PM10), nitrogen dioxide (NO2), and ozone (O3), aligning it more with the World Health Organization (WHO)'s 2021 air quality guidelines (AQGs).